Advertisement

Topics

Fulminant type 1 diabetes associated with nivolumab in a patient with metastatic melanoma.

08:00 EDT 1st April 2018 | BioPortfolio

Summary of "Fulminant type 1 diabetes associated with nivolumab in a patient with metastatic melanoma."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Melanoma research
ISSN: 1473-5636
Pages: 159-160

Links

DeepDyve research library

PubMed Articles [18042 Associated PubMed Articles listed on BioPortfolio]

Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC.

Programmed cell death-1 (PD-1) and programmed cell death-ligand-1 (PD-L1) inhibitors have been highlighted in the field of cancer treatment. The interaction between PD-1 and PD-L1 is thought to play a...

Acute-onset diabetes mellitus with ketoacidosis in a nivolumab-treated patient with hepatocellular carcinoma.

The therapy with immune checkpoint inhibitors (Programmed cell death-1 and programmed cell death-ligand-1 inhibitors) is a novel and promising approach in cancer treatment. The mode of action can caus...

Diabetes and Diet: A Patient and Dietitian's Perspective.

This article has been co-authored by a patient with type 2 diabetes and a specialist dietitian. Here they discuss the patient's experience and difficulties with controlling weight and strategies that ...

Association of Gestational Diabetes and Type 2 Diabetes Exposure In Utero With the Development of Type 2 Diabetes in First Nations and Non-First Nations Offspring.

Type 2 diabetes is increasing worldwide, disproportionately affecting First Nations (FN) people. Identifying early-life determinants of type 2 diabetes is important to address the intergenerational bu...

Translation and Validation of the Patient Activation Measure in Portuguese People with Type 2 Diabetes Mellitus.

Management of diabetes mellitus is largely dependent on patients' active participation in care. The 'Patient Activation Measure 13' assesses patients' knowledge, skills, and confidence in self-care. W...

Clinical Trials [10160 Associated Clinical Trials listed on BioPortfolio]

Clinical Assessment of New Treatment Regimen for Adult Fulminant Myocarditis

This is a retrospective cohort study to assess the clinical outcome of patients with fulminant myocarditis using "Life-support Based Comprehensive Treatment Regimen" and conventional thera...

Cerebral Microdialysis in Patients With Fulminant Hepatic Failure

Patients with fulminant hepatic failure (FHF) often develop cerebral edema, high intracranial pressure (ICP)that may result in fatal brain damage. The aim in this protocol is to determine ...

Implementation of A Patient Centered Self-Management Program for Patients With Type 2 Diabetes

Translational study based on the American Association of Diabetes Educators 7 behaviors to manage Type 2 diabetes

A Study of Nivolumab in Selected Uterine Cancer Patients

The purpose of this study is to test the safety of nivolumab and find out what affects, if any, nivolumab has on people and their risk of uterine cancer. The investigators also want to fin...

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Patients will be randomized to one of two treatment arms - Group I and Group II. In Group I, patients will receive nivolumab every 2 weeks for 12 weeks followed by surgery. Following rese...

Medical and Biotech [MESH] Definitions

The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

A severe type of hyperlipidemia, sometimes familial, that it is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .

Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Searches Linking to this Article